Europe · General news · El País

Los fármacos que vienen después del Ozempic: buscan adelgazar más, perder menos músculo y evitar el efecto rebote

Published by El País · Spain 2 h ago

Una revisión en ‘Science’ repasa la nueva generación de fármacos contra la obesidad. También avisa de que las patentes de los genéricos de semaglutida retrasarán su llegada a…

Read the full article on El País Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (elpais.com)

Also worth reading

Daily Mail

Millennial darling of the art world Lucien Smith's cause of death aged 37 revealed

Metro

Kev brings Nicola closer to Jimmy in Emmerdale as she enjoys his snoring

Evening Standard

England carry out Cole Palmer medical checks as Thomas Tuchel considers calling up Chelsea star

The Independent

Newsom commutes all 548 death sentences in California as he prepares to leave office

RTÉ

California governor commuting death sentences in state

Daily Mirror